CIK: 1585001 - Address: C/O Verve Therapeutics, Inc., 201 Brookline Avenue, Suite 601, Boston, MA 02215
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret113-114-25-35-18-12
S%wins6767331001006772

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/5/23 16:30
12/1/23
VERVVerve Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYeshwant KrishnaMADTP18,00010.0001,8001712,168I
11/8/22 17:51
11/4/22
VERVVerve Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYeshwant KrishnaMADTS-1,51331.140-49010,368I
11/4/22 17:58
11/2/22
VERVVerve Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYeshwant KrishnaMADTS.m-2,65533.950-78-110,466I
11/2/22 21:02
10/31/22
VERVVerve Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYeshwant KrishnaMADTS.m-3,25037.950-86-110,622I
8/10/17 16:07
8/8/17
FMIFoundation Medicine, Inc.DEHealthHealthMedical LaboratoriesYeshwant KrishnaMADS-19240.010-5-456D
8/8/17 16:04
8/4/17
FMIFoundation Medicine, Inc.DEHealthHealthMedical LaboratoriesYeshwant KrishnaMADS.d-66636.850-18-6311D
8/8/17 16:04
8/4/17
FMIFoundation Medicine, Inc.DEHealthHealthMedical LaboratoriesYeshwant KrishnaMADM.d32424.2101311D
6/15/15 20:09
6/11/15
FMIFoundation Medicine, Inc.DEHealthHealthMedical LaboratoriesYeshwant KrishnaCADTS.m-6,06332.9810-184-1000I4348-30-28-6-8-7-1-14-25-45-41
5/18/15 20:59
5/14/15
FMIFoundation Medicine, Inc.DEHealthHealthMedical LaboratoriesYeshwant KrishnaCADTS-33238.5712-9-4184I7748-24-24-16-15-6-5-2-10-41-53-49
6/17/14 17:20
6/13/14
FMIFoundation Medicine, Inc.DEHealthHealthMedical LaboratoriesYeshwant KrishnaCADS-29,12022.409-1,300-531,145I2-45-215-234517-8-835

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact